BeiGene Presents Results from SEQUOIA Trial of BRUKINSA (zanubrutinib) in First-Line Chronic Lymphocytic Leukemia at the 63rd ASH Annual Meeting
CAMBRIDGE, Mass. & BEIJING--(BUSINESS WIRE)--Dec 12, 2021--
Source: cadillacnews.com
Fast, Ad-Free News Updates
Stay updated with breaking news from Many Grade. Real-time updates on events, politics, business and more.